- Home
- ARVN vs RNST Comparison
ARVN vs RNST Comparison
Compare ARVN & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- RNST
- Stock Information
- Founded
- ARVN 2015
- RNST 1904
- Country
- ARVN United States
- RNST United States
- Employees
- ARVN N/A
- RNST N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- RNST Major Banks
- Sector
- ARVN Health Care
- RNST Finance
- Exchange
- ARVN Nasdaq
- RNST Nasdaq
- Market Cap
- ARVN 456.2M
- RNST 3.3B
- IPO Year
- ARVN 2018
- RNST N/A
- Fundamental
- Price
- ARVN $7.77
- RNST $38.15
- Analyst Decision
- ARVN Buy
- RNST Buy
- Analyst Count
- ARVN 21
- RNST 6
- Target Price
- ARVN $20.53
- RNST $42.20
- AVG Volume (30 Days)
- ARVN 1.8M
- RNST 564.3K
- Earning Date
- ARVN 07-29-2025
- RNST 07-22-2025
- Dividend Yield
- ARVN N/A
- RNST 2.31%
- EPS Growth
- ARVN N/A
- RNST 31.26
- EPS
- ARVN N/A
- RNST 3.20
- Revenue
- ARVN $426,900,000.00
- RNST $710,265,000.00
- Revenue This Year
- ARVN $4.26
- RNST $40.84
- Revenue Next Year
- ARVN N/A
- RNST $13.45
- P/E Ratio
- ARVN N/A
- RNST $11.91
- Revenue Growth
- ARVN 498.74
- RNST 15.97
- 52 Week Low
- ARVN $5.90
- RNST $26.97
- 52 Week High
- ARVN $34.11
- RNST $39.63
- Technical
- Relative Strength Index (RSI)
- ARVN 60.51
- RNST 65.98
- Support Level
- ARVN $7.68
- RNST $37.38
- Resistance Level
- ARVN $8.11
- RNST $38.49
- Average True Range (ATR)
- ARVN 0.36
- RNST 0.76
- MACD
- ARVN 0.05
- RNST 0.20
- Stochastic Oscillator
- ARVN 88.84
- RNST 91.92
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.